Alnylam Pharmaceuticals Inc
NasdaqGS:ALNY
$ 145.16
$-0.16 (-0.11%)
$ 145.16
$-0.16 (-0.11%)
End-of-day quote: 04/18/2024

ALNY - Alnylam Pharmaceuticals Inc Stock Prediction 2025 - 2030

20 years of reliable Alnylam Pharmaceuticals Inc stock forecast. The Wall Street analysts predict Outperform for ALNY. See at a glance whether NasdaqGS:ALNY will rise in the future.

$0.00
Forecast 2023
$174.04
Forecast 2025
$295.78
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$174.04
Forecast 2030
$295.78
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.4
Price-to-book Ratio
N/A
Market Cap
18.36B
TEV
18.74 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$245.24

Alnylam Pharmaceuticals Inc Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Alnylam Pharmaceuticals Inc Stock Forecast 2023

$215.00

In the last five quarters, Alnylam Pharmaceuticals Inc’s Price Target has fallen from $264.21 to $245.24 - a -7.18% decrease. Twenty-four analysts predict that Alnylam Pharmaceuticals Inc’s share price will fall in the coming year, reaching $215.00. This would represent a decrease of -12.33%.

48.11%
48.11
Last update: 04/19/2024

Highest Price Target $395.00

Average Price Target $215.00

Lowest Price Target $136.00

Alnylam Pharmaceuticals Inc Stock Predictions 2025

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Jan 2025.

In January 2025, analysts believe the stock price will be $157.98. An increase of 8.83% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Feb 2025.

In February 2025, analysts believe the stock price will be $159.44. An increase of 9.84% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Mar 2025.

In March 2025, analysts believe the stock price will be $160.90. An increase of 10.84% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Apr 2025.

In April 2025, analysts believe the stock price will be $162.36. An increase of 11.85% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in May 2025.

In May 2025, analysts believe the stock price will be $163.82. An increase of 12.85% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Jun 2025.

In June 2025, analysts believe the stock price will be $165.28. An increase of 13.86% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Jul 2025.

In July 2025, analysts believe the stock price will be $166.74. An increase of 14.86% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Aug 2025.

In August 2025, analysts believe the stock price will be $168.20. An increase of 15.87% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Sep 2025.

In September 2025, analysts believe the stock price will be $169.66. An increase of 16.88% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Oct 2025.

In October 2025, analysts believe the stock price will be $171.12. An increase of 17.88% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Nov 2025.

In November 2025, analysts believe the stock price will be $172.58. An increase of 18.89% compared to the previous month's estimate.

Stock Forecast for the Price of an Alnylam Pharmaceuticals Inc Share in Dec 2025.

In December 2025, analysts believe the stock price will be $174.04. An increase of 19.89% compared to the previous month's estimate.

Alnylam Pharmaceuticals Inc Stock Prediction 2030

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Jan 2030.

In Jan 2030 analysts predict a share price of $268.49. An increase of 84.96% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Feb 2030.

In Feb 2030 analysts predict a share price of $270.97. An increase of 86.67% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Mar 2030.

In Mar 2030 analysts predict a share price of $273.45. An increase of 88.38% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Apr 2030.

In Apr 2030 analysts predict a share price of $275.93. An increase of 90.09% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in May 2030.

In May 2030 analysts predict a share price of $278.41. An increase of 91.8% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Jun 2030.

In Jun 2030 analysts predict a share price of $280.90. An increase of 93.51% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Jul 2030.

In Jul 2030 analysts predict a share price of $283.38. An increase of 95.22% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Aug 2030.

In Aug 2030 analysts predict a share price of $285.86. An increase of 96.93% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Sep 2030.

In Sep 2030 analysts predict a share price of $288.34. An increase of 98.63% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Oct 2030.

In Oct 2030 analysts predict a share price of $290.82. An increase of 100.34% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Nov 2030.

In Nov 2030 analysts predict a share price of $293.30. An increase of 102.05% compared to today's share price.

Stock Prediction for the Price of One Alnylam Pharmaceuticals Inc Share in Dec 2030.

In Dec 2030 analysts predict a share price of $295.78. An increase of 103.76% compared to today's share price.

P/E
0.00
Beta
0.4
Price-to-book Ratio
N/A
Market Cap
18.36B
TEV
18.74 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$245.24

Alnylam Pharmaceuticals Inc Analyst Ratings Frequently Asked Questions

Who are the analysts watching Alnylam Pharmaceuticals Inc?

The following analysts have recently covered Alnylam Pharmaceuticals Inc:

Barclays
BMO Capital Markets Equity Research
BofA Global Research
CFRA Equity Research
Chardan Capital Markets, LLC
Citigroup Inc
Citigroup Inc. Research
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
H.C. Wainwright & Co.
J.P. Morgan
Jefferies LLC
Marktfeld
Morgan Stanley
Morningstar Inc.
Needham & Company
Oppenheimer & Co. Inc.
Piper Sandler Companies
RBC Capital Markets
Stifel
UBS Investment Bank
William Blair & Company L.L.C.
Baptista Research
Cantor Fitzgerald & Co.
Canaccord Genuity
Leerink Partners LLC
Raymond James & Associates
Sanford C. Bernstein & Co., LLC
TD Cowen
Wells Fargo Securities, LLC
Wolfe Research, LLC.
CGS International
Mirae Asset Securities Co., Ltd.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Alnylam Pharmaceuticals Inc?

The following sell-side analysts have recently covered Alnylam Pharmaceuticals Inc:

Wang, Huidong
Nachman, Gary Jay
Ahmad, Tazeen
Nakae, Keay Thomas
Lebowitz, David Neil
Baral, Ritu Subhalaksmi
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Trucchio, Patrick Ralph
Raycroft, Maurice Thomas
Paraskevopoulos, Michail
Elfman, Rachel
Stringer, Joseph Robert
Gershell, Leland James
Tenthoff, Edward Andrew
Issi, Luca
Matteis, Paul Andrew
Foroohar, Mani
Merle, Eliana Rachel
Bayko, Liisa Ann
Majumdar, Ishan
Brayer, Olivia Simone
Fye, Jessica Macomber
Biliouris, Konstantinos
Ijem, Whitney Glad
Hardy, Sel
Ulz, Michael Eric
Pickering, William
Fauth, Tiago Felipe
Chen, Gao Yi
Seo, Mihwa
Minter, Myles Robert
(This information refers to the last 90 days.)